PhRMA warns against tariffs as industry probe closes for commentsnews2025-05-07T18:47:57+00:00May 7th, 2025|Endpoints News|
Charles River launches ‘strategic review’ alongside activist investor Elliottnews2025-05-07T15:37:43+00:00May 7th, 2025|Endpoints News|
Trump, FDA zero in on foreign factories to give domestic sites an edge news2025-05-06T17:35:14+00:00May 6th, 2025|Endpoints News|
Investors unveil plans for $1.3B cancer hub in London suburbsnews2025-05-02T10:52:42+00:00May 2nd, 2025|Endpoints News|
Bristol Myers to close cell therapy site in Illinoisnews2025-05-01T18:42:48+00:00May 1st, 2025|Endpoints News|
Lilly CEO Ricks urges Trump to drop drug tariff plannews2025-05-01T18:33:22+00:00May 1st, 2025|Endpoints News|
GSK’s supply chain ‘reset’ after Haleon spinoff to ease tariff impact, CEO saysnews2025-04-30T11:17:19+00:00April 30th, 2025|Endpoints News|
Merck plans to shift Keytruda production to the USnews2025-04-29T15:37:48+00:00April 29th, 2025|Endpoints News|
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs nearnews2025-04-29T11:22:54+00:00April 29th, 2025|Endpoints News|
WuXi AppTec sees revenue growth after 2024’s declinenews2025-04-28T17:20:03+00:00April 28th, 2025|Endpoints News|
